Subject of the research is the treatment of liver fibrosis by developing novel cell-specific nanotherapeutics for the treatment of liver diseases

Ruchi Bansal

Subject of the research is the treatment of liver fibrosis by developing novel cell-specific nanotherapeutics for the treatment of liver diseases

Research output: Contribution to journal › Article › Popular

56 Downloads (Pure)

Abstract

Research Highlighted (Hoe Gaat Het Eigenlijk met Ruchi Bansal) in the NVH liver magazine (LEVER) of September 2015 (pages 7 & 9).

Original language	English
Pages (from-to)	7-9
Journal	Lever
Volume	39
Issue number	3
Publication status	Published - 2015

Access to Document

LEVER 3_15Final published version, 4.59 MB

http://www.hepatologie.org/files/LEVER%203_15.pdf

Cite this

@article{b02a0c48becc484680608326b4d790d8,

title = "Subject of the research is the treatment of liver fibrosis by developing novel cell-specific nanotherapeutics for the treatment of liver diseases",

abstract = "Research Highlighted (Hoe Gaat Het Eigenlijk met Ruchi Bansal) in the NVH liver magazine (LEVER) of September 2015 (pages 7 & 9).",

author = "Ruchi Bansal",

year = "2015",

language = "English",

volume = "39",

pages = "7--9",

journal = "Lever",

issn = "1574-7867",

publisher = "Nederlandse Vereniging voor Hepatologie",

number = "3",

}

TY - JOUR

T1 - Subject of the research is the treatment of liver fibrosis by developing novel cell-specific nanotherapeutics for the treatment of liver diseases

AU - Bansal, Ruchi

PY - 2015

Y1 - 2015

N2 - Research Highlighted (Hoe Gaat Het Eigenlijk met Ruchi Bansal) in the NVH liver magazine (LEVER) of September 2015 (pages 7 & 9).

AB - Research Highlighted (Hoe Gaat Het Eigenlijk met Ruchi Bansal) in the NVH liver magazine (LEVER) of September 2015 (pages 7 & 9).

M3 - Article

VL - 39

SP - 7

EP - 9

JO - Lever

JF - Lever

SN - 1574-7867

IS - 3

ER -